| Aug 8 |
Apyx Medical GAAP EPS of -$0.19 beats by $0.01, revenue of $12.14M beats by $0.39M
|
| Aug 8 |
Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Comparing the Use of Renuvion to a Competing Technology Following Liposuction or Body Contouring Procedures
|
| Aug 8 |
Apyx Medical Corporation Reports Second Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook
|
| Jul 25 |
At US$1.39, Is It Time To Put Apyx Medical Corporation (NASDAQ:APYX) On Your Watch List?
|
| Jul 25 |
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024
|
| Jul 1 |
Calculating The Fair Value Of Apyx Medical Corporation (NASDAQ:APYX)
|
| Jun 26 |
Apyx Medical Corporation Launches the "Renewing Lives" Give-Back Campaign Providing Treatments with Renuvion to Benefit Physical Appearance and Mental Health
|
